Cargando…
Drug Holidays and Overall Survival of Patients with Metastatic Colorectal Cancer
SIMPLE SUMMARY: During first-line treatment of metastatic colorectal cancer, drug holidays (DHs) are usually adopted to limit toxicity. Literature lacks a formal demonstration that first-line continuous treatment, or maintenance, provides longer overall survival compared to DHs. We retrospectively s...
Autores principales: | Garattini, Silvio Ken, Basile, Debora, Bonotto, Marta, Ongaro, Elena, Porcu, Luca, Corvaja, Carla, Cattaneo, Monica, Andreotti, Victoria Josephine, Lisanti, Camilla, Bertoli, Elisa, Pelizzari, Giacomo, Iacono, Donatella, Miolo, Gianmaria, Cardellino, Giovanni Gerardo, Buonadonna, Angela, Aprile, Giuseppe, Fasola, Gianpiero, Puglisi, Fabio, Pella, Nicoletta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304309/ https://www.ncbi.nlm.nih.gov/pubmed/34298718 http://dx.doi.org/10.3390/cancers13143504 |
Ejemplares similares
-
The SAFFO Study: Sex-Related Prognostic Role and Cut-Off Definition of Monocyte-to-Lymphocyte Ratio (MLR) in Metastatic Colorectal Cancer
por: Lisanti, Camilla, et al.
Publicado: (2022) -
The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients
por: Basile, Debora, et al.
Publicado: (2019) -
Molecular classifications of gastric cancers: Novel insights and possible future applications
por: Garattini, Silvio Ken, et al.
Publicado: (2017) -
Non-small cell lung cancer harboring EGFR G724S mutation and exon 19 deletion responded to afatinib monotherapy after multiple lines of target therapies
por: Cortiula, Francesco, et al.
Publicado: (2022) -
First- and second-line treatment strategies for hormone-receptor (HR)-positive HER2-negative metastatic breast cancer: A real-world study
por: Basile, Debora, et al.
Publicado: (2021)